How effective is Daytrana for Narcolepsy? (a real world drug study)
Summary:
Overall ratings: 3/5 Long term ratings: 2.9/5
This is a phase IV clinical study of how effective Daytrana (methylphenidate) is for Narcolepsy and for what kind of people. The study is created by eHealthMe from 12 Daytrana users and is updated continuously.
What is Daytrana?
Daytrana has active ingredients of methylphenidate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 16,561 Daytrana users. Check the latest studies of Daytrana.
What is Narcolepsy?
Narcolepsy (brain's inability to regulate sleep-wake cycles normally) is found to be associated with 431 drugs and 738 conditions by eHealthMe. Check the latest studies of Narcolepsy.
12 people are studied for taking Daytrana in Narcolepsy
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Daytrana effectiveness for Narcolepsy (number of people):
Overall:
- not at all: 0
- somewhat: 2
- moderate: 8
- high: 2
- very high: 0
Long Term:
- not at all: 0
- somewhat: 2
- moderate: 6
- high: 1
- very high: 0
Gender of people who take Daytrana for Narcolepsy *:
- female: 58.33 %
- male: 41.67 %
Age of people who take Daytrana for Narcolepsy *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 8.33 %
- 40-49: 33.33 %
- 50-59: 50.0 %
- 60+: 8.33 %
Who find Daytrana more effective for Narcolepsy?
Gender of people who take Daytrana for Narcolepsy *:
- female: 0.0 %
- male: 100 %
Age of people who take Daytrana for Narcolepsy *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 50 %
- 40-49: 0.0 %
- 50-59: 50 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Daytrana?
- You can start a phase IV clinical trial to monitor Daytrana safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
- Han SH, Lee SA, "Superficial Vein Thrombosis as the Initial Manifestation of Protein S Deficiency in an Adolescent with Narcolepsy", Sleep Medicine Research, 2016 Jun .
- Lopes E, Pereira D, da Silva Behrens NS, de Almeida Fonseca H, Calvancanti PO, de Araújo Lima TF, Pradella-Hallinan M, Castro J, Tufik S, Coelho FM, "Cataplexy as a side effect of modafinil in a patient without narcolepsy", Sleep Science, 2014 Mar .
Related studies
Alternative drugs to, pros and cons of:
- Daytrana (16,561 reports)
Treatments, associated drugs and conditions:
- Narcolepsy (79,888 reports)
How the study uses the data?
The study is based on methylphenidate (the active ingredients of Daytrana) and Daytrana (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Leflunomide and Borage - 8 seconds ago
- Could Bisoprolol Fumarate cause Dissociation? - 13 seconds ago
- Drug interactions of Proscar and Simponi - 18 seconds ago
- Could Alendronic Acid cause Dyspnea? - 23 seconds ago
- Drug interactions of Proscar and Intron A - 23 seconds ago
- Could Lanreotide Acetate cause Fatigue Aggravated? - 34 seconds ago
- Could Trospium Chloride cause Hypoaesthesia? - 35 seconds ago
- Drug interactions of Propranolol Hydrochloride and Pegasys - 41 seconds ago
- Drug interactions of Latuda and Aripiprazole - 43 seconds ago
- Drug interactions of Breo Ellipta and Pred Forte - 45 seconds ago